Reduced Morbidity and Mortality in Survivors of Childhood Acute Lymphoblastic Leukemia: A Report From the Childhood Cancer Survivor Study

Study in 6,148 survivors of childhood ALL found that the 20-year all-cause late mortality was 6.6%. Authors highlight that risk -stratified therapy has reduced late morbidity and mortality among contemporary survivors of standard-risk ALL.


Journal of Clinical Oncology